Evidence map›Paper›PMID 31381611›Full record

ArticlePloS one2019

Antimicrobial use in an Indonesian community cohort 0-18 months of age.

Jarir At Thobari, Cahya Dewi Satria, Yohanes Ridora, Emma Watts, Amanda Handley, Samad Samad, Novilia S Bachtiar, Julie E Bines, Yati Soenarto, Jim P Buttery

Abstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jarir At ThobariPediatric Research Office, Department of Pediatrics, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Special Region of Yogyakarta, Indonesia.ORCID 0000-0002-7035-4846
Cahya Dewi SatriaPediatric Research Office, Department of Pediatrics, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Special Region of Yogyakarta, Indonesia.
Yohanes RidoraPediatric Research Office, Department of Pediatrics, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Special Region of Yogyakarta, Indonesia.
Emma WattsRV3 Rotavirus Vaccine Program, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
Amanda HandleyRV3 Rotavirus Vaccine Program, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
Samad SamadSoeradji Tirtonegoro General Hospital, Klaten, Central Java, Indonesia.
Novilia S BachtiarPT Bio Farma, Bandung, West Java, Indonesia.
Julie E BinesRV3 Rotavirus Vaccine Program, Murdoch Children's Research Institute, Parkville, Victoria, Australia.ORCID 0000-0002-5452-6601
Yati SoenartoPediatric Research Office, Department of Pediatrics, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Special Region of Yogyakarta, Indonesia.
Jim P ButteryRV3 Rotavirus Vaccine Program, Murdoch Children's Research Institute, Parkville, Victoria, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAntimicrobial resistance has become a global health emergency and is contributed to by inappropriate antibiotic use in community clinical settings. The aim of this study was to evaluate the antimicrobial use pattern in infants from birth until 18 months of age in Indonesia.

methodsA post-hoc analysis was conducted in 1621 participants from the RV3BB Phase IIb trial conducted in Indonesia from January 2013 through July 2016. Any health events were documented in the trial as adverse events. Concomitant medication surveillance recorded all medications, including antibiotics during the 18 months of follow-up. Information included the frequency, duration of usage, formulation, classes, and their indications, including prophylactic antibiotic and perinatal use.

resultsOf 1621 participants, 551 (33.99%) received at least one antibiotic for treatment of infections during the 18 months observation period. Additionally, during the perinatal period, prophylactic antibiotics were used in 1244 (76.74%) participants and antibiotics consumed in 235 mothers of participants (14.50%). A total of 956 antibiotic consumptions were recorded for 18 months follow up, 67 (7.01%) as part of antimicrobial combinations. The average duration of antibiotic course was 4.92 days. Penicillin and sulfonamides were the most common antibiotic classes consumed (38.81% and 24.48%, respectively).

conclusionsDespite the low community consumption rate, the overuse of antibiotic in URTIs and non-bloody diarrhea in our setting represents a major opportunity for antimicrobial stewardship, particularly in early life.

Indexed as

Anti-Bacterial AgentsAntimicrobial StewardshipClinical Trials, Phase III as TopicCohort StudiesDrug Resistance, BacterialFemaleHumansIndonesiaInfantInfant, NewbornMalePerinatal CareResidence CharacteristicsAnti-Bacterial Agents

Identifiers

PMID31381611
PMCPMC6681970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.